.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Argus Health
Covington
Colorcon
Novartis
Dow
Medtronic
Citi
Chinese Patent Office
Daiichi Sankyo

Generated: June 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 007073

« Back to Dashboard
NDA 007073 describes AZULFIDINE, which is a drug marketed by Pharmacia And Upjohn and is included in three NDAs. It is available from five suppliers. Additional details are available on the AZULFIDINE profile page.

The generic ingredient in AZULFIDINE is sulfasalazine. There are ten drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.

Summary for NDA: 007073

Tradename:
2
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 007073

Ingredient-typeAminosalicylic Acids

Suppliers and Packaging for NDA: 007073

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AZULFIDINE EN-TABS
sulfasalazine
TABLET, DELAYED RELEASE;ORAL 007073 NDA Pharmacia and Upjohn Company LLC 0013-0101 0013-0101-01 100 TABLET in 1 BOTTLE (0013-0101-01)
AZULFIDINE EN-TABS
sulfasalazine
TABLET, DELAYED RELEASE;ORAL 007073 NDA Pharmacia and Upjohn Company LLC 0013-0101 0013-0101-20 300 TABLET in 1 BOTTLE (0013-0101-20)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, DELAYED RELEASE;ORALStrength500MG
Approval Date:Apr 6, 1983TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Accenture
Mallinckrodt
Express Scripts
Moodys
QuintilesIMS
Medtronic
Healthtrust
Julphar
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot